Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin Lymphoma, Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07631598
What this trial is testing

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

Who this might be right for
Opioid Use DisorderOpioid Use Disorder, SevereOpioid Use Disorder, Moderate
Montefiore Medical Center 512
Testing effectiveness (Phase 2)Study completedNCT00446095
What this trial is testing

Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma

Who this might be right for
Lymphoma
Rigel Pharmaceuticals 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07031700
What this trial is testing

A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL

Who this might be right for
Relapsed/Refractory Follicular Lymphoma
Tianjin Medical University Cancer Institute and Hospital 22
Early research (Phase 1)Study completedNCT00005634
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00475332
What this trial is testing

Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar

Who this might be right for
Non-Hodgkin's LymphomaFollicular Lymphoma
University of Florida 2
Early research (Phase 1)Ended earlyNCT02031419
What this trial is testing

Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Celgene 174
Testing effectiveness (Phase 2)Ended earlyNCT00152841
What this trial is testing

Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn's DiseaseUlcerative ColitisMild or Moderate Anaemia
University Health Network, Toronto 30
Not applicableUnknownNCT05728801
What this trial is testing

Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study

Who this might be right for
Age-related Cognitive DeclineCognitive DeteriorationDementia, Mild
Chinese University of Hong Kong 400
Testing effectiveness (Phase 2)Study completedNCT00022581
What this trial is testing

Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+1 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Looking for participantsNCT06213636
What this trial is testing

Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).

Who this might be right for
Acute Lymphoblastic Leukemia, Adult B-CellAcute Lymphoblastic Leukemia, in RelapseNon-Hodgkin Lymphoma, B-cell+4 more
Essen Biotech 75
Testing effectiveness (Phase 2)UnknownNCT00026429
What this trial is testing

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Pharmatech Oncology
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Not applicableUnknownNCT05167929
What this trial is testing

Self-determination Enhancement Group for Adults With Mild Intellectual Disability and Their Caregivers in Hong Kong

Who this might be right for
Intellectual Disability, Mild
Chinese University of Hong Kong 120
Large-scale testing (Phase 3)Study completedNCT01546142
What this trial is testing

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Who this might be right for
Moderate or Severe Submental Fullness
Kythera Biopharmaceuticals 516
Early research (Phase 1)Active Not RecruitingNCT04468841
What this trial is testing

Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Memorial Sloan Kettering Cancer Center 77
Not applicableLooking for participantsNCT06444841
What this trial is testing

Paper-Based and Smartphone-Based Memory Supports

Who this might be right for
Alzheimer DiseaseDementia, MildMild Cognitive Impairment
Baylor University 200
Testing effectiveness (Phase 2)Study completedNCT00004145
What this trial is testing

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Chicago 16
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Large-scale testing (Phase 3)UnknownNCT00003639
What this trial is testing

Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Scotland and Newcastle Lymphoma Group 200
Testing effectiveness (Phase 2)Study completedNCT00859001
What this trial is testing

Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy

Who this might be right for
Follicular Lymphoma
University of Bologna 55
Next Page